Sonnet BioTherapeutics (SONN) P/E (2020 - 2025)
Sonnet BioTherapeutics (SONN) P/E from Jun 30, 2020 to Dec 2, 2025. The TTM Sonnet BioTherapeutics (SONN) P/E is -0.31. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Sonnet BioTherapeutics (SONN)
| Year | P/E | Change |
|---|---|---|
| 2025 | -0.31 | -53.46% |
| 2024 | -0.66 | -40.41% |
| 2023 | -1.11 | -55.14% |
| 2022 | -2.48 | -73.53% |
| 2021 | -9.35 | -65.58% |
| 2020 | -27.17 | N/A |
Comparison Sonnet BioTherapeutics (SONN) P/E with competitors
Sonnet BioTherapeutics (SONN) P/E is -0.31.